About Vasomeditech
Vasomeditech is a Healthcare company. Healthcare solutions for cardiovascular treatments and diagnostics in India. The company has 17 employees. Its Indian entity Vaso-Meditech Private Limited reported revenue of ₹5.91 Cr. Vasomeditech offers products and services including EECP and SphygmoCor. Its focus areas include Medical Devices, Cardiovascular Treatments, Non-Invasive Therapies and Diagnostics.
Company details
Vasomeditech is recognized for providing non-invasive medical treatments and devices aimed at cardiovascular care, with a focus on EECP therapy that has been approved and studied extensively. The company is associated with historical advancements in India, including government programs and clinical publications, where treatments are delivered to patients with arterial issues or post-surgical needs. Operations are managed through training centers and support services, emphasizing safety and external methods without risks, as evidenced by global trials and patient outcomes.
- Employees 17
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Vaso-Meditech Private Limited
- Date of Incorporation 30 Mar, 2001
- Jurisdiction Chennai, Tamil Nadu, India
- Indian entity revenue₹5.91 Cr
FY 2024 · -32% YoY
- Indian entity net profit₹59.7 Lakh
FY 2024 · 10% margin
- Indian entity EBITDA₹1.04 Cr
FY 2024 · 18% margin
- Employee Count17
Associated legal entities of Vasomeditech
Vasomeditech operates through Vaso-Meditech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vaso-Meditech Private Limited CIN U51507TN2001PTC046887 | Active | 30 Mar 2001 | Chennai, Tamil Nadu | ₹5.9 Cr | 17 | 2 | View details |
Products & Services of Vasomeditech
Vasomeditech offers a comprehensive portfolio of products and services, including EECP and SphygmoCor.
EECP is offered as a non-invasive treatment for cardiovascular conditions, where it is used to counter heart functions externally and improve blood flow without invasive procedures.
SphygmoCor is employed as a device for assessing arterial functions and providing reports on cardiovascular health, supporting patient evaluations in clinical settings.
Board of directors of Vaso-Meditech Private Limited (Vasomeditech)
Vaso-Meditech Private Limited is the primary company behind Vasomeditech. The board of Vaso-Meditech Private Limited currently have 2 directors; the longest-serving is Ramasamy Subramanian, appointed in 2001. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ramasamy Subramanian DIN 01884672 | Director | 30 Mar 2001 | 25 yrs 6 mo | Vaso-Meditech Private Limited |
| Priya Devi Ramasamy DIN 01941792 | Director | 01 Mar 2008 | 18 yrs 7 mo | Vaso-Meditech Private Limited |
Financials of Vasomeditech
Figures of Vaso-Meditech Private Limited, the primary company behind Vasomeditech, for FY 2024. Revenue was ₹5.91 Cr (-32% year on year). Net profit was ₹59.7 Lakh (10% margin). EBITDA was ₹1.04 Cr (18% margin). Revenue has grown at a compounded annual rate of +36% over three years and +11% over five years.
- ₹5.91 CrRevenue · FY 2024 · -32% YoY
- ₹59.7 LakhNet profit · 10% margin
- ₹1.04 CrEBITDA · 18% margin
- ₹50 LakhPaid-up capital
- 17Employees (provident fund records)
- +36%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vaso-Meditech Private Limited are on its company page.
Detailed financial statements for Vasomeditech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vasomeditech
Vasomeditech has 17 employees.
The primary company behind Vasomeditech, Vaso-Meditech Private Limited, reported revenue of ₹5.91 Cr for FY 2024, down 32% year on year.
Vasomeditech is recognized for providing non-invasive medical treatments and devices aimed at cardiovascular care, with a focus on EECP therapy that has been approved and studied extensively. The company is associated with historical advancements in India, including government programs and clinical publications, where treatments are delivered to patients with arterial issues or post-surgical needs. Operations are managed through training centers and support services, emphasizing safety and external methods without risks, as evidenced by global trials and patient outcomes.
Vasomeditech offers EECP and SphygmoCor.
Vasomeditech operates through Vaso-Meditech Private Limited.
The legal entities of Vasomeditech currently have 2 directors, including Priya Devi Ramasamy, Ramasamy Subramanian.